The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹21.05Fair value₹34.97Bull₹52.83
FairClose
52-week traded range
52W low ₹18.4952W high ₹32.15
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Mukka Proteins Limited closed at ₹30.57, 12.6% below the consensus fair value of ₹34.97 drawn from 9 valuation models.
Financial DNA score 43/100 — Average. P/E of 14.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹34.54
+13.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹28.53
-6.7%
√(22.5 × EPS × BVPS)
EPS=1.74, BVPS=20.8
Graham Formula
₹52.83
+72.8%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=12.1%, FD=7%
P/E Fair Value
₹35.15
+15.0%
EPS × 20.2x (sector P/E)
EPS=1.74, Sector P/E=20.2x
Peter Lynch (PEG)
₹21.05
-31.1%
EPS × Growth% (PEG = 1 is fair)
EPS=1.74, g=12.1%
EV/EBITDA
₹42.44
+38.8%
(EBITDA × 16.1x − Net Debt) ÷ Shares
EBITDA=1.32B
Book Value (P/B)
₹26.51
-13.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=20.8, ROE=11.1%, g=6%, r=10%
Reverse DCF
₹30.57
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5.4% | Historical: 12.1%
Margin of Safety
₹28.32
-7.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=37.76, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.